A recently published scientific article suggests that fenbendazole (and similar drugs) could potentially reactivate the p53 genome. Functioning as a tumor suppressor, p53 is known as the Custodian of the Genome. However, its inhibitory capacity may be reduced in some types of cancer. Check out this drug that really helps in the fight against cancer.